We are live on ! Find out more
VHAQ.WS

Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS

Delisted

VHAQ.WS was delisted on the 23rd of October, 2023.

32 hedge funds and large institutions have $6.21M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3232 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

36% less capital invested

Capital invested by funds: $9.75M → $6.21M (-$3.54M)

60% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 10

Holders
32
Holders Change
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
10
Closed
3
Calls
$2.18M
Puts
Net Calls
+$2.18M
Net Calls Change
+$12K
Name Holding Trade Value Shares
Change
Change in
Stake
SM
26
Skaana Management
New York
$5K
VF
27
Virtu Financial
New York
$1K -$918 -7,168 -35%
OMC
28
Old Mission Capital
Illinois
$1K +$393 +3,074 +31%
ASM
29
ATW SPAC Management
New York
$29 +$23.4K +182,601 +100%
PSAMP
30
P. Schoenfeld Asset Management (PSAM)
New York
-$119K -550,333 Closed
Blackstone Inc
31
Blackstone Inc
New York
-$87K -400,000 Closed
GCL
32
Glazer Capital LLC
New York
-$14K -65,680 Closed
UBS Group
33
UBS Group
Switzerland
-$858 -6,707 -78%
Morgan Stanley
34
Morgan Stanley
New York
-$714 -5,575 -100%

VHAQ.WS Hedge Fund Activity: Q1 2022 in Review

32 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q1 2022, worth a combined $6.21M — down 36% from $9.75M a quarter earlier.

Fund positioning in VHAQ.WS was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 10 trimmed.

The largest buyer was ATW SPAC Management, adding an estimated $23.4K. The largest seller was P. Schoenfeld Asset Management (PSAM), exiting entirely with an estimated $119K sold.

  • 32 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $6.21M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q1 2022, down 36% quarter-over-quarter.
  • 3 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q1 2022 and 3 closed out, a net change of 0 holders.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q1 2022 was ATW SPAC Management, an estimated $23.4K added.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q1 2022 was P. Schoenfeld Asset Management (PSAM), an estimated $119K sold.

Based on aggregated 13F filings for Q1 2022.